Announces Executive and Employee Reductions and Cost Saving Measures VANCOUVER, BC, March 16, 2022 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”), announced today that a special committee of the Company’s board of directors (the “Special Committee”) has concluded the initial phases of its previously announced strategic review process (the…


Previous articleEntheon Biomedical Announces Enrollment in Phase 1 Study of DMT
Next articleGreen Market Report – Are Psychedelics Leaving Minorities Behind?